"Cancer Vaccine Test Has Promising Result"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

------------------------------------------------------------

October 14, 2002

U.S. IMMUNIZATION NEWS

New York Times (www.nytimes.com) (10/14/02) P. C7

Results of a clinical trial involving New York-based biotechnology company Antigenics' experimental cancer vaccine, which were published in the Journal of Clinical Oncology, determined that the vaccine was able to virtually eliminate tumors in two of 28 patients with advanced melanoma. Antigenics' vaccine, known as HSPPC-96, has a similar success rate as Interleukin-2, which is approved to treat advanced melanoma; however, HSPPC-96 shows little toxicity, unlike Interleukin-2. The Antigenics vaccine, which is in the final phase of clinical testing, is custom-made for each patient, using cells from their tumors and works by encouraging the patient's immune system to fight the cancerous cells.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider

Copyright 2010 by Vaccination News, A Non-Profit Corporation. All Rights Reserved. This content may not be copied unless permission in writing from Sandy Gottstein has been obtained.

To Subscribe and/or
Donate Click HERE

"A foolish faith in authority is the worst enemy of truth."

-- Albert Einstein, letter to a friend, 1901

"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."

-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820

Sandy's Scandals Column

Past and current Scandals - columns by Sandy Gottstein (aka Mintz)*

03/09/10 - VAERS - Is the Joke On Us?

03/05/10 - Sleepwalking Through Vaccine-Land

02/08/10 - Political Science and You!

See full list of columns here

Picks of the Day Samples

For the full Picks of the Day Sample click HERE

* ►March 20, 2010 - H1N1 Vaccine Acceptability and Correlates of Vaccine Refusal Among Physicians in the Emory Residency Training Programs - Fifth Decennial International Conference on Healthcare-Associated Infections (abstract) - "The results suggest H1N1 vaccination coverage may be increased by making vaccination mandatory or by focusing on vaccine safety messages that address the perceived risk of active influenza infection."

* ►March 20, 2010 - Taking the Final Step: Implementation of a Mandatory Flu Shot Program Within a Healthcare System - Fifth Decennial International Conference on Healthcare-Associated Infections (abstract) - "Exemption from vaccination was allowed for egg allergy, history of either Guillian-Barré or a post-flu shot anaphylaxis. A formal exemption process began as a written appeal to an internal review board which determined exemption. For the non-exempt, the choice to not be vaccinated resulted in termination. Rehire is conditional, based on the intent to comply with influenza vaccination in the future. ...Over 99.99% of approximately 3800 employees received a seasonal flu shot. No serious side effects occurred among those receiving vaccine. Of those employees who applied for exemption but were denied, 4 chose to terminate employement; however, one of these, a physician, chose retirement rather than immunization. Consequences for unvaccinated, non-employees were not explored this initial year."

* ►March 19, 2010 - Autism, Vaccines, Thimerosal: Further Study Needed - Age of Autism - "No study has looked at the possible effect of the synergistic toxicity of aluminum and thimerosal, which are never supposed to be used in combination (according to the Manufacturer Safety Data Sheet (MSDS) for thimerosal ) and are indeed combined in many shots (according to the Vaccine Excipient Summary from the CDC). And no controlled study, not one, exists on the effect of low dose ethyl mercury toxicity in humans (a statement made by study author Anders Hviid himself below on p.1765)."

* ►March 18, 2010 - FDA to Ease Way for Multidrug Regimens (MRK,AZN) - SmarTrend News Watch via COMTEX via Trading Markets - "At least two pharmaceutical consortia are poised to take advantage of the forthcoming policy: a group of 10 drug companies and several nonprofit organizations convened by the Bill and Melinda Gates Foundation to develop medicines to fight tuberculosis; and pharmaceutical giants Merck & Co. (NYSE: MRK | Quote | Chart | News | PowerRating) and AstraZeneca PLC (NYSE: AZN | Quote | Chart | News | PowerRating), which are jointly testing two anticancer agents."

User login

Primary Links